Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
The paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improve...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Endocrinology Research Centre
2013-03-01
|
| Series: | Ожирение и метаболизм |
| Subjects: | |
| Online Access: | https://www.omet-endojournals.ru/jour/article/view/5071 |
| _version_ | 1797204706856009728 |
|---|---|
| collection | DOAJ |
| description | The paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improved sexual function without causing severe side effects. A number of patients on therapy observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation. |
| first_indexed | 2024-03-08T09:14:43Z |
| format | Article |
| id | doaj.art-ee23bcd862fd4dbbb5882ee580f4a5c5 |
| institution | Directory Open Access Journal |
| issn | 2071-8713 2306-5524 |
| language | English |
| last_indexed | 2024-04-24T08:39:30Z |
| publishDate | 2013-03-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Ожирение и метаболизм |
| spelling | doaj.art-ee23bcd862fd4dbbb5882ee580f4a5c52024-04-16T16:16:08ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242013-03-01101434610.14341/2071-8713-50715029Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in menThe paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improved sexual function without causing severe side effects. A number of patients on therapy observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation.https://www.omet-endojournals.ru/jour/article/view/5071testosterone undecanoateobesitymetabolic syndromemenhypogonadismandrogen therapy |
| spellingShingle | Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men Ожирение и метаболизм testosterone undecanoate obesity metabolic syndrome men hypogonadism androgen therapy |
| title | Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
| title_full | Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
| title_fullStr | Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
| title_full_unstemmed | Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
| title_short | Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
| title_sort | experience of using long acting testosterone undecanoate in hypogonadism obesity and metabolic syndrome in men |
| topic | testosterone undecanoate obesity metabolic syndrome men hypogonadism androgen therapy |
| url | https://www.omet-endojournals.ru/jour/article/view/5071 |